RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Atsushi Nara to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Atsushi Nara has written about Xenograft Model Antitumor Assays.
Atsushi Nara
Connection Strength
0.213
Xenograft Model Antitumor Assays
  1. Nara A, Shimada S, Akiyama Y, Hatano M, Chino Y, Miyazawa S, Tamura H, Asano D, Ishikawa Y, Ueda H, Watanabe S, Katsuta E, Akahoshi K, Ohashi K, Tanabe M, Ban D, Tanaka S. Targeting SPP1-CD44-Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis. Cancer Sci. 2026 Mar; 117(3):670-682.
    View in: PubMed
    Score: 0.213
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support